PASSAGE BIO, INC. Marketable Securities, Unrealized Gain (Loss)
PASSAGE BIO, INC. (PASG) reported Marketable Securities, Unrealized Gain (Loss) of -$8.00 thousand for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-09-03.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-09-03
- PASSAGE BIO, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was $0.00.
- PASSAGE BIO, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PASSAGE BIO, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- PASSAGE BIO, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-03-31 was -$8.00K.
- PASSAGE BIO, INC. marketable securities, unrealized gain (loss) for fiscal 2023 was $923.00K.
- PASSAGE BIO, INC. marketable securities, unrealized gain (loss) for fiscal 2022 was -$553.00K.
- PASSAGE BIO, INC. marketable securities, unrealized gain (loss) for fiscal 2021 was -$401.00K.
- PASSAGE BIO, INC. marketable securities, unrealized gain (loss) for fiscal 2020 was -$12.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 3 month as first filed | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 9 month as first filed | Marketable Securities, Unrealized Gain (Loss) 12 month | Marketable Securities, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-03 | $0.00 derived: sum of 2 quarters · filed 2026-09-03 | $0.00 derived: sum of 3 quarters · filed 2026-09-03 | -$8.00K S-4/A · filed 2026-09-03 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − S-4/A 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-09-03 | -$8.00K 10-Q · filed 2025-11-10 | -$32.00K derived: sum of 4 quarters · filed 2026-09-03 | |||
| 2025-06-30 | $0.00 derived: S-4/A 6 month − S-4 3 month · filed 2026-09-03 | -$8.00K S-4/A · filed 2026-09-03 | -$32.00K derived: sum of 3 quarters · filed 2026-09-03 | $67.00K derived: sum of 4 quarters · filed 2026-09-03 | |||
| 2025-03-31 | -$8.00K S-4 · filed 2026-07-21 | -$32.00K derived: sum of 2 quarters · filed 2026-09-03 | $67.00K derived: sum of 3 quarters · filed 2026-09-03 | $69.00K derived: sum of 4 quarters · filed 2026-09-03 | |||
| 2024-12-31 | -$24.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-03 | $75.00K derived: sum of 2 quarters · filed 2026-09-03 | $77.00K derived: sum of 3 quarters · filed 2026-09-03 | $51.00K S-4/A · filed 2026-09-03 | |||
| 2024-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $101.00K derived: sum of 2 quarters · filed 2025-11-10 | $75.00K 10-Q · filed 2025-11-10 | $224.00K derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$24.00K 10-Q · filed 2025-08-12 | $125.00K derived: sum of 3 quarters · filed 2025-08-12 | $273.00K derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | -$26.00K 10-Q · filed 2025-05-13 | $123.00K derived: sum of 2 quarters · filed 2025-05-13 | $271.00K derived: sum of 3 quarters · filed 2025-05-13 | $358.00K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $297.00K derived: sum of 2 quarters · filed 2025-03-04 | $384.00K derived: sum of 3 quarters · filed 2025-03-04 | $923.00K 10-K · filed 2025-03-04 | |||
| 2023-09-30 | $148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $235.00K derived: sum of 2 quarters · filed 2024-11-13 | $774.00K 10-Q · filed 2024-11-13 | $1.28M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $626.00K 10-Q · filed 2024-08-08 | $1.13M derived: sum of 3 quarters · filed 2024-08-08 | $1.24M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $539.00K 10-Q · filed 2024-05-14 | $1.04M derived: sum of 2 quarters · filed 2024-05-14 | $1.15M derived: sum of 3 quarters · filed 2024-05-14 | $907.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $502.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $612.00K derived: sum of 2 quarters · filed 2024-03-04 | $368.00K derived: sum of 3 quarters · filed 2024-03-04 | -$553.00K 10-K · filed 2024-03-04 | |||
| 2022-09-30 | $110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$134.00K derived: sum of 2 quarters · filed 2023-11-13 | -$1.05M 10-Q · filed 2023-11-13 | -$1.50M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$1.17M 10-Q · filed 2023-08-07 | -$1.61M derived: sum of 3 quarters · filed 2023-08-07 | -$1.60M derived: sum of 4 quarters · filed 2023-08-07 | |||
| 2022-03-31 | -$921.00K 10-Q · filed 2023-05-11 | -$1.37M derived: sum of 2 quarters · filed 2023-05-11 | -$1.35M derived: sum of 3 quarters · filed 2023-05-11 | -$1.32M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$432.00K derived: sum of 2 quarters · filed 2023-03-06 | -$396.00K derived: sum of 3 quarters · filed 2023-03-06 | -$401.00K 10-K · filed 2023-03-06 | |||
| 2021-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $50.00K derived: sum of 2 quarters · filed 2022-11-10 | $45.00K 10-Q · filed 2022-11-10 | $73.00K derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $31.00K 10-Q · filed 2022-08-04 | $59.00K derived: sum of 3 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$5.00K 10-Q · filed 2022-05-16 | $5.00K 10-Q · filed 2021-05-05 | $23.00K derived: sum of 2 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$12.00K 10-K · filed 2022-03-03 | $12.00K 10-K · filed 2021-03-03 | ||||
| 2020-09-30 | -$40.00K 10-Q · filed 2021-11-04 | $40.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |